Neutrophilulymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer: A systematic review and meta-analysis

被引:66
作者
Tsai, Po-Li [1 ]
Su, Wei-Ju [2 ]
Leung, Wei-Hung [1 ]
Lai, Cheng-Ta [1 ]
Liu, Chien-Kuo [1 ]
机构
[1] Mackay Mem Hosp, Dept Surg, Div Colorectal Surg, Zhongshan, Taiwan
[2] Mackay Mem Hosp, Hosp Palliat Care Ctr, Taipei, Taiwan
关键词
Carcinoembryonic antigen; colorectal cancer; meta-analysis; neutrophil-lymphocyte ratio; prognosis; NEUTROPHIL-LYMPHOCYTE RATIO; ELEVATED PREOPERATIVE NEUTROPHIL; PRETREATMENT NEUTROPHIL; TUMOR RESPONSE; CARCINOEMBRYONIC ANTIGEN; CURATIVE SURGERY; POOR-PROGNOSIS; RECTAL-CANCER; NEUTROPHIL/LYMPHOCYTE RATIO; CIRCULATING LYMPHOCYTE;
D O I
10.4103/0973-1482.144356
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: There is a growing body of evidence showing the functional relationship between inflammation index like netrophil.lymphocyte ratio. (NLR) and colorectal cancer. (CRC) in both experimental and clinical situations. The serum carcinoembryonic antigen. (CEA) level is the most widely used marker and associate with poor prognosis in most studies. For these factors to be clinically useful, they should be routinely available, well standardized, and validated in different patient cohorts. Aims: There is a growing body of evidence showing the functional relationship between inflammation index like netrophil-lymphocyte ratio. (NLR) and colorectal cancer. (CRC) in both experimental and clinical situations. The serum carcinoembryonic antigen. (CEA) level is the most widely used marker and associate with poor prognosis in most studies. For these factors to be clinically useful, they should be routinely available, well standardized, and validated in different patient cohorts. Materials and Methods: We systemically searched PubMed, Embase, and SciVerse Scopus databases, and performed a meta.analysis by Review Manager 5.2 software. (The Cochrane Collaboration, Software Update, Oxford). Two reviewers selected studies, assessed risk of bias, and extracted data independently. Newcastle.Ottawa Scale was applied to assess the quality of included studies. Results: Fifteen studies involving 7741 patients with CRC were analyzed. Patients with an NLR 5 before treatment were significantly more likely to have 5-year overall survival (odds ratio [OR] = 2.03; 95% confidence interval [CI] = 1.56-2.63) and 5-year disease-free survival (OR = 1.67; 95% CI = 1.19-2.35). Pretreatment CEA level 5 were significantly associated with complete tumor response and tumor downstaging after neoadjuvant treatment. The result also showed that patients with NLR 5 were expected to have a larger tumor, poorer tumor differentiation, and higher CEA level. Conclusion: NLR and CEA are valuable tools for the prediction of prognosis in CRC and adjusting the treatment strategy.
引用
收藏
页码:582 / 589
页数:8
相关论文
共 48 条
[1]   Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer [J].
Allin, Kristine H. ;
Nordestgaard, Borge G. .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (04) :155-170
[2]   The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme [J].
Bambury, R. M. ;
Teo, M. Y. ;
Power, D. G. ;
Yusuf, A. ;
Murray, S. ;
Battley, J. E. ;
Drake, C. ;
O'Dea, P. ;
Bermingham, N. ;
Keohane, C. ;
Grossman, S. A. ;
Moylan, E. J. ;
O'Reilly, S. .
JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) :149-154
[3]   Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? [J].
Carriquiry, LA ;
Piñeyro, A .
DISEASES OF THE COLON & RECTUM, 1999, 42 (07) :921-929
[4]   Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer [J].
Carruthers, R. ;
Tho, L. M. ;
Brown, J. ;
Kakumanu, S. ;
McCartney, E. ;
McDonald, A. C. .
COLORECTAL DISEASE, 2012, 14 (10) :E701-E707
[5]   Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer [J].
Cedres, S. ;
Torrejon, D. ;
Martinez, A. ;
Martinez, P. ;
Navarro, A. ;
Zamora, E. ;
Mulet-Margalef, N. ;
Felip, E. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (11) :864-869
[6]   Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? [J].
Chiang, Sum-Fu ;
Hung, Hsin-Yuan ;
Tang, Reiping ;
Chung Rong Changchien ;
Chen, Jinn-Shiun ;
You, Yau-Tong ;
Chiang, Jy-Ming ;
Lin, Jr-Rung .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (10) :1347-1357
[7]   Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment [J].
Cho, HanByoul ;
Hur, Hye Won ;
Kim, Sang Wun ;
Kim, Sung Hoon ;
Kim, Jae Hoon ;
Kim, Young Tae ;
Lee, Kook .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (01) :15-23
[8]   Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer [J].
Choi, Chi Hwan ;
Kim, Won Dong ;
Lee, Sang Jeon ;
Park, Woo-Yoon .
RADIATION ONCOLOGY JOURNAL, 2012, 30 (03) :99-107
[9]   Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer [J].
Chua, W. ;
Charles, K. A. ;
Baracos, V. E. ;
Clarke, S. J. .
BRITISH JOURNAL OF CANCER, 2011, 104 (08) :1288-1295
[10]  
Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979